6-168057275-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024919.6(FRMD1):c.1472T>A(p.Leu491Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000875 in 1,612,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024919.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMD1 | NM_024919.6 | c.1472T>A | p.Leu491Gln | missense_variant | 11/11 | ENST00000283309.11 | NP_079195.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMD1 | ENST00000283309.11 | c.1472T>A | p.Leu491Gln | missense_variant | 11/11 | 1 | NM_024919.6 | ENSP00000283309 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152140Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000106 AC: 26AN: 245992Hom.: 0 AF XY: 0.0000824 AC XY: 11AN XY: 133506
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1460054Hom.: 0 Cov.: 59 AF XY: 0.0000441 AC XY: 32AN XY: 726346
GnomAD4 genome AF: 0.000460 AC: 70AN: 152258Hom.: 0 Cov.: 34 AF XY: 0.000470 AC XY: 35AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.1472T>A (p.L491Q) alteration is located in exon 11 (coding exon 11) of the FRMD1 gene. This alteration results from a T to A substitution at nucleotide position 1472, causing the leucine (L) at amino acid position 491 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at